荣泰健康
(603579)
| 流通市值：34.22亿 | | | 总市值：34.22亿 |
| 流通股本：2.01亿 | | | 总股本：2.01亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 990,807,574.01 | 442,196,878.4 | 1,572,896,808.32 | 1,148,150,857.84 |
| 营业总成本 | 952,524,887.11 | 421,907,631.52 | 1,519,345,912.84 | 1,091,080,657.84 |
| 其他经营收益 | | | | |
| 营业利润 | 110,186,881.24 | 67,556,795.75 | 183,929,321.78 | 128,936,198.05 |
| 利润总额 | 110,106,381.29 | 67,551,221.98 | 184,424,740.49 | 130,092,260.91 |
| 净利润 | 109,792,792.99 | 69,183,681.07 | 149,995,750.58 | 110,868,486.23 |
| 每股收益 | | | | |
| 其他综合收益 | -165,069.61 | -149,882.19 | 29,553,817.39 | 29,747,484.62 |
| 综合收益总额 | 109,627,723.38 | 69,033,798.88 | 179,549,567.97 | 140,615,970.85 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,330,536,041.34 | 2,315,725,848.32 | 2,173,955,792.72 | 1,944,519,563.58 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,574,355,039.37 | 1,473,486,804.08 | 1,400,174,141.11 | 1,403,444,211.72 |
| 资产总计 | 3,904,891,080.71 | 3,789,212,652.4 | 3,574,129,933.83 | 3,347,963,775.3 |
| 流动负债: | | | | |
| 流动负债合计 | 1,038,858,096.16 | 812,468,413.58 | 704,521,474.86 | 528,282,788.37 |
| 非流动负债: | | | | |
| 非流动负债合计 | 77,126,676.75 | 81,762,813.08 | 81,279,992.4 | 68,141,401.49 |
| 负债合计 | 1,115,984,772.91 | 894,231,226.66 | 785,801,467.26 | 596,424,189.86 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,759,201,599.38 | 2,864,622,103.64 | 2,785,374,218.68 | 2,747,982,971.64 |
| 股东权益合计 | 2,788,906,307.8 | 2,894,981,425.74 | 2,788,328,466.57 | 2,751,539,585.44 |
| 负债和股东权益合计 | 3,904,891,080.71 | 3,789,212,652.4 | 3,574,129,933.83 | 3,347,963,775.3 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,065,861,352.63 | 477,335,108.69 | 1,832,824,608.14 | 1,375,989,761.7 |
| 经营活动现金流出小计 | 1,067,490,284.52 | 560,033,642.49 | 1,658,053,221.42 | 1,304,426,102.93 |
| 经营活动产生的现金流量净额 | -1,628,931.89 | -82,698,533.8 | 174,771,386.72 | 71,563,658.77 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,160,418,822.01 | 808,768,056.75 | 4,855,621,088.59 | 3,696,254,298.41 |
| 投资活动现金流出小计 | 2,401,137,924.39 | 957,349,359.08 | 4,636,351,607.27 | 3,504,932,409.73 |
| 投资活动产生的现金流量净额 | -240,719,102.38 | -148,581,302.33 | 219,269,481.32 | 191,321,888.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 450,876,997.61 | 202,182,501.41 | 364,332,834.05 | 274,156,927.89 |
| 筹资活动现金流出小计 | 321,492,345.6 | 82,717,440.3 | 683,570,271.94 | 611,713,020.76 |
| 筹资活动产生的现金流量净额 | 129,384,652.01 | 119,465,061.11 | -319,237,437.89 | -337,556,092.87 |
| 汇率变动对现金及现金等价物的影响 | -7,978,454.56 | -3,472,824.91 | -1,817,953.94 | 189,047.38 |
| 现金及现金等价物净增加额 | -120,941,836.82 | -115,287,599.93 | 72,985,476.21 | -74,481,498.04 |
| 期末现金及现金等价物余额 | 450,814,426.83 | 456,468,663.72 | 571,756,263.65 | 424,289,289.4 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -120,941,836.82 | - | 72,985,476.21 | - |
最新报告期：2026-09-17| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 刘一怡 | 0.88 | 1.06 | 1.21 | 2026-09-17 |
| 长江证券 | 陈亮 | 0.75 | 1.15 | 1.29 | 2026-08-26 |